As we approach the end of the first quarter of 2020, investment fund managers and investors in non-traded or infrequently traded debt and equity investments have a fiduciary duty to report independent and credible fair value information to investors and stakeholders. This process is complicated by the rapidly changing global health situation due to the coronavirus (COVID-19). Given the uncertainty demonstrated in the public markets and the unknown ultimate impact of COVID-19, using informed judgment to measure the fair value of investments will require even more thought and analysis.
Please join us for a discussion on how best to reflect the impact of COVID-19 on measuring and reporting fair value for the March 31, 2020 quarter end.
Schedule: 12:00 p.m. - 1:00 p.m. (EDT)
- What impact will COVID-19 have on fair value estimates at March 31, 2020?
- How are market participants transacting in times of increased uncertainty?
- How are value drivers impacted by the epidemic (revenue, cost, growth, competition, market conditions, etc.)?
- Should projections be updated and what is the impact on fair value if they have not been updated?
- How much weight should be placed on observable market transactions and public market volatility?
- What are the short, medium and long-term impacts of a market disruption on the business and operations of an investee company?
- David Larsen, Managing Director, Portfolio Valuation, U.S.
- Ross Hostetter, Managing Director, Portfolio Valuation, U.S.
- Ryan McNelley, Managing Director, Portfolio Valuation, EMEA
- David Scott, Managing Director and Co-Leader Energy & Mining, Portfolio Valuation, U.S.
CPE credit will be provided.
Please submit your questions in advance of the webcast by sending a message to us at [email protected]